Generation of high quantities of viral and tumor-specific human CD4 + and CD8 + T-cell clones using peptide pulsed mature dendritic cells

Journal of Immunological Methods

Volumn 258, Issue 1-2, 2001, Pages 111-126

  Fonteneau, Jean François ^a   Larsson, Marie ^a   Somersan, Selin ^a   Sanders, Catherine ^a   Münz, Christian ^a   Kwok, William W ^b   Bhardwaj, Nina ^a   Jotereau, Francine ^c  

^a ROCKEFELLER UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c INSTITUT DE BIOLOGIE   (France)

Author keywords

Adoptive immunotherapy; Dendritic cells; Human T cell clones; Viral and tumor immunity

Indexed keywords

ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; EPITOPE; GAMMA INTERFERON; HLA ANTIGEN; INTERLEUKIN 2; MELANOMA ANTIGEN; PEPTIDE; TETRAMER;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANTIGEN DETECTION; ANTIGEN SPECIFICITY; ARTICLE; CANCER IMMUNOTHERAPY; CELL CLONE; CELL STIMULATION; CLONOGENESIS; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOLYSIS; DENDRITIC CELL; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; MARMOSET; MONOCYTE; MONONUCLEAR CELL; NONHUMAN; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; STAINING; STEM CELL; T LYMPHOCYTE; TECHNIQUE; VIRUS IMMUNITY;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CLONE CELLS; DENDRITIC CELLS; HLA ANTIGENS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERFERON TYPE II; MELANOMA; MOLECULAR SEQUENCE DATA; ORTHOMYXOVIRIDAE; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA;

EID: 0035545692     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(01)00477-X     Document Type: Article

References (27)

1. Human T lymphocyte clones reactive in primed lymphocyte typing and cytotoxicity
2. Inactivated influenza virus, when presented on dendritic cells, elicits human CD8 + cytolytic T cell responses
3. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood
4. Cancer tumor antigens
5. In vivo migration and function of transferred HIV-1 specific cytotoxic T cells
6. Coordinate regulation of complex T cell populations responding to bacterial infection
7. Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes
8. Rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma
9. Heterogeneity of biological responses of melanoma specific CT L
10. The distinct surface of human blood dendritic cells, as observed after an improved isolation method
11. High avidity melanoma-reactive cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocytes on stimulation by peptide-pulsed melanoma cells
12. Detection of intracellular cytokines by flow cytometry
13. A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals
14. Requirement of mature dendritic cells for efficient activation of influenza A-specific Memory CD8 + T cells
15. Analysis and sorting of live cells according to secreted molecules, relocated to a cell-surface affinity matrix
16. T-cell immunotherapy of tumors by adoptive transfer of cytotoxic T lymphocytes and by vaccination with minimal essential epitopes
17. MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen
18. High scale expansion of melanoma reactive TIL by a polyclonal stimulus: Predictibility and relation with disease advancement
19. The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells
20. T-cell therapy of cytomegalovirus and human immunodeficiency virus infection
21. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients
22. In vivo activity of in vitro immunized lymphocytes: I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes
23. Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues
24. Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3
25. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor
26. Human T cell clones as a diagnostic tools and potential therapeutic reagents
27. Melanocyte destruction after antigen-specific immunotherapy of melanoma. Direct evidence of T cell-mediated vitiligo